Table 4.
Unadjusted proportional incidence ratios (PIR) of patients diagnosed with a non-AIDS-defining cancer at least 3 months after an HIV/AIDS diagnosis by patient and tumor characteristics, Iowa, 1991–2015.
| HIV/AIDS Population | Iowa Population | PIR | 95% CI | ||
|---|---|---|---|---|---|
| (N=234) | (N=415,753) | ||||
| Cancer diagnosis | 1991–1998 | 26 | 124,248 | 0.37 | (0.26, 0.53) |
| year | 1999–2006 | 57 | 130,999 | 0.77 | (0.62, 0.97) |
| 2007–2015 | 151 | 160,506 | 1.67 | (1.52, 1.84) | |
| Cancer diagnosis | 00–29 | 11 | 10,115 | 1.93 | (1.09, 3.44) |
| age (years) | 30–39 | 32 | 12,398 | 4.59 | (3.32, 6.33) |
| 40–49 | 75 | 30,673 | 4.34 | (3.60, 5.24) | |
| 50+ | 116 | 362,567 | 0.57 | (0.50, 0.65) | |
| Race | White | 192 | 404,992 | 0.84 | (0.79, 0.89) |
| African American | 34 | 5,686 | 10.62 | (7.79, 14.50) | |
| Other | 8 | 5,075 | 2.80 | (1.42, 5.53) | |
| Sex | Female | 37 | 206,987 | 0.32 | (0.24, 0.43) |
| Male | 197 | 208,766 | 1.68 | (1.59, 1.77) | |
| Area of residence | Metro | 154 | 207,214 | 1.11 | (1.01, 1.22) |
| (68,611 missing) | Non-metro | 78 | 139,932 | 0.83 | (0.70, 1.00) |
| Insurance status | Insured | 83 | 145,174 | 0.63 | (0.55, 0.73) |
| (248,439 missing) | Medicaid | 49 | 6,019 | 9.03 | (7.17, 11.37) |
| Uninsured | 19 | 16,287 | 1.29 | (0.85, 1.97) | |
| Site / Histology | Anus and Anal Canal / Squamous Cell Neoplasms | 41 | 900 | 80.94 | (61.30, 106.88) |
| Anus and Anal Canal / Other | 5 | 356 | 24.95 | (10.48, 59.39) | |
| Female Genital Organs / Squamous Cell Neoplasms | 12 | 5,102 | 4.18 | (2.41, 7.25) | |
| Liver and Intrahepatic Bile Duct / Adenocarcinomas | 12 | 3,419 | 6.24 | (3.59, 10.82) | |
| Lung and Bronchus / Adenocarcinomas | 19 | 19,444 | 1.74 | (1.13, 2.67) | |
| Lung and Bronchus / Squamous Cell Neoplasms | 8 | 12,710 | 1.12 | (0.57, 2.21) | |
| Lung and Bronchus / Other | 10 | 25,531 | 0.70 | (0.38, 1.28) | |
| Lymph Nodes / Other | 20 | 2,558 | 13.89 | (9.14, 21.12) | |
| Male Genital Organs / Adenocarcinomas | 9 | 51,050 | 0.31 | (0.17, 0.59) | |
| Male Genital Organs / Squamous Cell Neoplasms | 7 | 532 | 23.38 | (11.27, 48.49) | |
| Male Genital Organs / Other | 6 | 6,868 | 1.55 | (0.70, 3.42) | |
| Oral Cavity and Pharynx / Squamous Cell Neoplasms | 6 | 6,930 | 1.54 | (0.70, 3.39) | |
| Other Sites / Adenocarcinomas | 23 | 96,040 | 0.43 | (0.29, 0.63) | |
| Other Sites / Ductal and Lobular Neoplasms | 7 | 60,989 | 0.20 | (0.10, 0.42) | |
| Other Sites / Leukemias | 9 | 13,377 | 1.20 | (0.63, 2.27) | |
| Other Sites / Squamous Cell Neoplasms | 10 | 9,415 | 1.89 | (1.03, 3.46) | |
| Other Sites / Other | 30 | 100,532 | 0.53 | (0.38, 0.74) |
*
Significantly elevated PIRs are bolded